Carl Buising Joins ManTech’s Federal Health IT Unit as Chief Medical Officer; Daniel Keefe Comments

Carl Buising
Carl Buising

Dr. Carl Buising, formerly federal chief medical officer at Leidos (NYSE: LDOS), has joined ManTech International’s (NASDAQ: MANT) federal health information technology division as chief medical officer.

The certified physician will bring his two decades of health IT and medicine experience to his current role and help ManTech promote the adoption of IT systems among medical providers, the company said Thursday.

“Dr. Buising’s medical background and executive leadership will be invaluable as we continue to bridge the gap between healthcare providers and technology, ” said Daniel J. Keefe, president and chief operating officer of ManTech’s mission solutions and services group.

Buising has held leadership roles at Microsoft (NASDAQ: MSFT) and I*MD Consulting and is also a former medical officer in the U.S. Army.

He graduated from the University of California at Irvine with a bachelor’s degree in biology and received his medical doctorate degree from Bethesda, Maryland-based Uniformed Services University of the Health Sciences.

Buising completed his family medicine residency at Georgia-based Martin Army Community Hospital.

You may also be interested in...

Young Bang, Chief Growth Officer for Atlas Research

Atlas Joins DMI-Led Air Force Enterprise Transformation Contract Team; Young Bang Quoted

Atlas Research is part of a Digital Mobilizations Inc.-led team that won a position on a five-year, $990M contract vehicle to help the U.S. Air Force implement and manage enterprise transformation initiatives.

HIMARS launcher

State Dept OKs $1.8B in HIMARS Launchers, Recce Pods, Missile Purchase Requests From Taiwan

The State Department has approved Taiwan’s request to buy high mobility artillery rocket system launchers, AGM-84H standoff land attack missile-expanded response systems, MS-110 recce pods and related equipment and services under three foreign military sales agreements worth approximately $1.8B combined.